WHO Expert Committee on Drug Dependence : thirty-third report.
| Μορφή: | Βιβλίο |
|---|---|
| Γλώσσα: | English |
| Έκδοση: |
Geneva :
World Health Organization,
2003.
|
| Σειρά: | WHO technical report series ;
915 |
| Θέματα: |
MARC
| LEADER | 00000cam a2200000 u 4500 | ||
|---|---|---|---|
| 001 | 2007 | ||
| 003 | GrATPDL | ||
| 005 | 20231010171325.0 | ||
| 008 | 130912s2003 g b s eng d | ||
| 020 | |a 9241209151 | ||
| 040 | |a GrATPDL |d ΕΘΝΙΚΗ ΣΧΟΛΗ ΔΗΜΟΣΙΑΣ ΥΓΕΙΑΣ-ΚΕΝΤΡΙΚΗ ΒΙΒΛΙΟΘΗΚΗ |c ΠΑΝΕΠΙΣΤΗΜΙΟΥΠΟΛΗ ΑΘΗΝΩΝ | ||
| 041 | 0 | |a eng | |
| 245 | 0 | 0 | |a WHO Expert Committee on Drug Dependence : |b thirty-third report. |
| 260 | |a Geneva : |b World Health Organization, |c 2003. | ||
| 300 | |a vi, 26 σ. ; |c 24 εκ. | ||
| 490 | 0 | |a WHO technical report series ; |v 915 | |
| 504 | |a Περιέχει βιβλιογραφίες. | ||
| 505 | |a Contents; 1. Introduction; 2. Scheduling criteria; 3. Critical review of psychoactive substances; 4. Pre-review of psychoactive substances; 5. Terminology used in reporting abuse-related adverse drug reactions; 6. Other matters; Acknowledgements; References; Annex Terminology used in reporting abuse-related adverse drug reactions; References; | ||
| 650 | 0 | |a Substance abuse. |9 4068 | |
| 650 | 0 | |a Χρήση ουσιών. |9 4069 | |
| 650 | 0 | |a Drugs. |9 3908 | |
| 650 | 0 | |a Φάρμακα. |9 352 | |
| 760 | 1 | |a WHO TECHNICAL REPORT SERIES |g 915 | |
| 942 | |2 ddc |c BK |h 616.86 WHO |6 616_860000000000000_WHO | ||
| 952 | |0 0 |1 0 |2 ddc |4 0 |6 616_860000000000000_WHO |7 1 |9 2886 |a MAIN |b MAIN |d 2020-01-10 |l 0 |o 616.86 WHO |p 00002064 |r 2020-01-10 |t 1 |w 2020-01-10 |y BK | ||
| 999 | |c 2476 |d 2476 | ||
Εγγραφή στο Ευρετήριο Αναζήτησης
| _version_ | 1784614217684353024 |
|---|---|
| building | Campus Library III |
| collection | LIB3 Catalog |
| contents | Contents; 1. Introduction; 2. Scheduling criteria; 3. Critical review of psychoactive substances; 4. Pre-review of psychoactive substances; 5. Terminology used in reporting abuse-related adverse drug reactions; 6. Other matters; Acknowledgements; References; Annex Terminology used in reporting abuse-related adverse drug reactions; References; |
| format | Book |
| fullrecord | {"leader":"01442cam a2200277 u 4500","fields":[{"001":"2007"},{"003":"GrATPDL"},{"005":"20231010171325.0"},{"008":"130912s2003 g b s eng d"},{"020":{"subfields":[{"a":"9241209151"}],"ind1":" ","ind2":" "}},{"040":{"subfields":[{"a":"GrATPDL"},{"d":"\u0395\u0398\u039d\u0399\u039a\u0397 \u03a3\u03a7\u039f\u039b\u0397 \u0394\u0397\u039c\u039f\u03a3\u0399\u0391\u03a3 \u03a5\u0393\u0395\u0399\u0391\u03a3-\u039a\u0395\u039d\u03a4\u03a1\u0399\u039a\u0397 \u0392\u0399\u0392\u039b\u0399\u039f\u0398\u0397\u039a\u0397"},{"c":"\u03a0\u0391\u039d\u0395\u03a0\u0399\u03a3\u03a4\u0397\u039c\u0399\u039f\u03a5\u03a0\u039f\u039b\u0397 \u0391\u0398\u0397\u039d\u03a9\u039d"}],"ind1":" ","ind2":" "}},{"041":{"subfields":[{"a":"eng"}],"ind1":"0","ind2":" "}},{"245":{"subfields":[{"a":"WHO Expert Committee on Drug Dependence :"},{"b":"thirty-third report."}],"ind1":"0","ind2":"0"}},{"260":{"subfields":[{"a":"Geneva :"},{"b":"World Health Organization,"},{"c":"2003."}],"ind1":" ","ind2":" "}},{"300":{"subfields":[{"a":"vi, 26 \u03c3. ;"},{"c":"24 \u03b5\u03ba."}],"ind1":" ","ind2":" "}},{"490":{"subfields":[{"a":"WHO technical report series ;"},{"v":"915"}],"ind1":"0","ind2":" "}},{"504":{"subfields":[{"a":"\u03a0\u03b5\u03c1\u03b9\u03ad\u03c7\u03b5\u03b9 \u03b2\u03b9\u03b2\u03bb\u03b9\u03bf\u03b3\u03c1\u03b1\u03c6\u03af\u03b5\u03c2."}],"ind1":" ","ind2":" "}},{"505":{"subfields":[{"a":"Contents; 1. Introduction; 2. Scheduling criteria; 3. Critical review of psychoactive substances; 4. Pre-review of psychoactive substances; 5. Terminology used in reporting abuse-related adverse drug reactions; 6. Other matters; Acknowledgements; References; Annex Terminology used in reporting abuse-related adverse drug reactions; References;"}],"ind1":" ","ind2":" "}},{"650":{"subfields":[{"a":"Substance abuse."},{"9":"4068"}],"ind1":" ","ind2":"0"}},{"650":{"subfields":[{"a":"\u03a7\u03c1\u03ae\u03c3\u03b7 \u03bf\u03c5\u03c3\u03b9\u03ce\u03bd."},{"9":"4069"}],"ind1":" ","ind2":"0"}},{"650":{"subfields":[{"a":"Drugs."},{"9":"3908"}],"ind1":" ","ind2":"0"}},{"650":{"subfields":[{"a":"\u03a6\u03ac\u03c1\u03bc\u03b1\u03ba\u03b1."},{"9":"352"}],"ind1":" ","ind2":"0"}},{"760":{"subfields":[{"a":"WHO TECHNICAL REPORT SERIES"},{"g":"915"}],"ind1":"1","ind2":" "}},{"942":{"subfields":[{"2":"ddc"},{"c":"BK"},{"h":"616.86 WHO"},{"6":"616_860000000000000_WHO"}],"ind1":" ","ind2":" "}},{"952":{"subfields":[{"0":"0"},{"1":"0"},{"2":"ddc"},{"4":"0"},{"6":"616_860000000000000_WHO"},{"7":"1"},{"9":"2886"},{"a":"MAIN"},{"b":"MAIN"},{"d":"2020-01-10"},{"l":"0"},{"o":"616.86 WHO"},{"p":"00002064"},{"r":"2020-01-10"},{"t":"1"},{"w":"2020-01-10"},{"y":"BK"}],"ind1":" ","ind2":" "}},{"999":{"subfields":[{"c":"2476"},{"d":"2476"}],"ind1":" ","ind2":" "}}]}
|
| id | lib3_2476 |
| illustrated | Not Illustrated |
| institution | University of West Attica |
| isbn | 9241209151 |
| language | English |
| physical | vi, 26 σ. ; 24 εκ. |
| publishDate | 2003 |
| publisher | World Health Organization, |
| record_format | marc |
| series2 | WHO technical report series ; |
| spelling | WHO Expert Committee on Drug Dependence : thirty-third report. Geneva : World Health Organization, 2003. vi, 26 σ. ; 24 εκ. WHO technical report series ; 915 Περιέχει βιβλιογραφίες. Contents; 1. Introduction; 2. Scheduling criteria; 3. Critical review of psychoactive substances; 4. Pre-review of psychoactive substances; 5. Terminology used in reporting abuse-related adverse drug reactions; 6. Other matters; Acknowledgements; References; Annex Terminology used in reporting abuse-related adverse drug reactions; References; Substance abuse. 4068 Χρήση ουσιών. 4069 Drugs. 3908 Φάρμακα. 352 WHO TECHNICAL REPORT SERIES 915 |
| spellingShingle | WHO Expert Committee on Drug Dependence : thirty-third report. Contents; 1. Introduction; 2. Scheduling criteria; 3. Critical review of psychoactive substances; 4. Pre-review of psychoactive substances; 5. Terminology used in reporting abuse-related adverse drug reactions; 6. Other matters; Acknowledgements; References; Annex Terminology used in reporting abuse-related adverse drug reactions; References; Substance abuse. 4068 Χρήση ουσιών. 4069 Drugs. 3908 Φάρμακα. 352 |
| title | WHO Expert Committee on Drug Dependence : thirty-third report. |
| title_auth | WHO Expert Committee on Drug Dependence : thirty-third report. |
| title_full | WHO Expert Committee on Drug Dependence : thirty-third report. |
| title_fullStr | WHO Expert Committee on Drug Dependence : thirty-third report. |
| title_full_unstemmed | WHO Expert Committee on Drug Dependence : thirty-third report. |
| title_short | WHO Expert Committee on Drug Dependence : |
| title_sort | who expert committee on drug dependence thirty third report |
| title_sub | thirty-third report. |
| topic | Substance abuse. 4068 Χρήση ουσιών. 4069 Drugs. 3908 Φάρμακα. 352 |
| topic_facet | Substance abuse. Χρήση ουσιών. Drugs. Φάρμακα. |